Answers are grounded in this paper and cite their sources.
Analysis reveals differences in gut microbiota among patients with multiple myeloma, suggesting potential impact on CAR-T therapy outcomes.
Supplementary Figure S15 identifies significantly different relative abundances of bacterial families in the gut microbiota of multiple myeloma (MM) patients compared to healthy donors (HD). This figure presents mean relative abundances ± SD for various bacterial families, with individual dots representing MM patients or healthy donors, and statistical significance indicated by asterisks based on Mann-Whitney test results.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: